SEC Form 4 · accession 0001127602-16-048908
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg H Alton
Officer — EVP, Corp & Med Affairs
Period of report
Apr 1, 2016
Accepted (ET)
Apr 5, 2016 · 7:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 1, 2016 | S | 5,000 | $91.2315 | D | 142,090 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale prices reported for the transactions reported here range from $91.11 to $91.34. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.